HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The localization of plasminogen activator inhibitor-1 in glomerular subepithelial deposits in membranous nephropathy.

Abstract
In this study, the localization of plasminogen activator inhibitor-1 (PAI-1) and its association with glomerular subepithelial deposits of vitronectin (VN) in membranous nephropathy (MN) was evaluated. Renal biopsy tissue from 30 patients with MN along with specimens of normal kidney removed from six patients with renal tumors were examined for glomerular deposits of urokinase-type plasminogen activator, tissue-type plasminogen activator (t-PA), PAI-1, VN, and fibrinogen by using immunofluorescence and immunoelectron microscopic techniques. Deposits were characterized by pretreating the frozen sections with arginine, glycine, and t-PA to dissociate the VN-PAI-1 complexes, thus providing evidence of PAI-1 binding to VN. Glomeruli isolated from normal frozen kidney and from frozen kidney tissue with MN were subjected to immunoblot analysis. VN was found in the mesangial area and t-PA was observed along the capillary wall of normal glomeruli. Coarse granular deposits of VN, PAI-1, and t-PA were observed along the glomerular basement membrane in MN. Immunoelectron microscopy showed the presence of VN, PAI-1, and t-PA in the subepithelial immune deposits. Pretreating the samples with arginine decreased or abolished immunofluorescence staining for PAI-1 and t-PA, but not for VN. Pretreatment with t-PA decreased the immunofluorescence staining for PAI-1, but not for VN. Pretreatment with glycine decreased or abolished the staining for all three proteins. Immunoblot analysis revealed the presence of VN, PAI-1, t-PA, and t-PA-PAI-1 complex in glomeruli with MN as well as the presence of VN, but not of PAI-1, t-PA, or complex in the normal glomeruli. The findings from this study strongly suggest that PAI-1 was deposited in the glomeruli in MN as a result of binding to VN. Thus, VN-associated PAI-1 may injure the integrity of the fibrinolytic system in glomeruli affected by MN.
AuthorsT Nakamura, N Tanaka, N Higuma, T Kazama, I Kobayashi, S Yokota
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 7 Issue 11 Pg. 2434-44 (Nov 1996) ISSN: 1046-6673 [Print] United States
PMID8959637 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Plasminogen Activator Inhibitor 1
  • Vitronectin
  • Fibrinogen
  • Tissue Plasminogen Activator
Topics
  • Biopsy
  • Epithelium (metabolism)
  • Fibrinogen (analysis)
  • Fluorescent Antibody Technique, Indirect
  • Glomerulonephritis, Membranous (metabolism, pathology)
  • Humans
  • Immunoblotting
  • Kidney Glomerulus (metabolism, ultrastructure)
  • Microscopy, Fluorescence
  • Microscopy, Immunoelectron
  • Plasminogen Activator Inhibitor 1 (metabolism)
  • Tissue Plasminogen Activator (metabolism)
  • Vitronectin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: